$13.59
al cierre: Oct 28 EDT
$13.60
0.010000.07%
Pre-comercialización: 4:41 AM EDT
Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
10x Genomics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
nov 6
Estimación de BPA
$-0.150
Estimación de ingresos trimestrales
$142.47M
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$644.47M
Analice el historial de beneficios de 10x Genomics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
TXG | 10x Genomics | -$0.30 | -$0.15 | — | — | $151.65M | $142.47M | — | — | 11/06/2025 | |
TXG | 10x Genomics | -$0.32 | -$0.19 | $0.28 | 247.37% | $153.10M | $139.48M | $172.90M | 23.96% | 08/07/2025 | |
TXG | 10x Genomics | -$0.50 | -$0.29 | -$0.28 | 3.45% | $141.01M | $131.91M | $154.88M | 17.42% | 05/08/2025 | |
TXG | 10x Genomics | -$0.24 | -$0.11 | -$0.40 | -263.64% | $183.98M | $164.98M | $165.02M | 0.02% | 02/12/2025 | |
TXG | 10x Genomics | -$0.79 | -$0.34 | -$0.30 | 11.76% | $153.64M | $158.63M | $151.65M | -4.40% | 10/29/2024 | |
TXG | 10x Genomics | -$0.53 | -$0.47 | -$0.32 | 31.91% | $146.82M | $150.74M | $153.10M | 1.57% | 08/08/2024 | |
TXG | 10x Genomics | -$0.44 | -$0.50 | -$0.50 | 0.00% | $134.28M | $142.24M | $141.01M | -0.87% | 04/30/2024 | |
TXG | 10x Genomics | -$0.15 | -$0.36 | -$0.24 | 33.33% | $156.23M | $182.80M | $183.98M | 0.64% | 02/15/2024 | |
TXG | 10x Genomics | -$0.37 | -$0.46 | -$0.44 | 4.35% | $131.07M | $151.26M | $153.64M | 1.58% | 11/02/2023 | |
TXG | 10x Genomics | -$0.57 | -$0.39 | -$0.53 | -35.90% | $114.61M | $138.97M | $146.82M | 5.65% | 08/03/2023 | |
TXG | 10x Genomics | -$0.38 | -$0.37 | -$0.44 | -18.92% | $114.50M | $128.82M | $134.28M | 4.24% | 05/03/2023 | |
TXG | 10x Genomics | -$0.16 | -$0.31 | -$0.15 | 51.61% | $143.53M | $148.69M | $156.23M | 5.07% | 02/15/2023 | |
TXG | 10x Genomics | -$0.15 | -$0.46 | -$0.37 | 19.57% | $125.30M | $129.58M | $131.07M | 1.15% | 11/02/2022 | |
TXG | 10x Genomics | -$0.10 | -$0.39 | -$0.57 | -46.15% | $115.84M | $117.19M | $114.61M | -2.20% | 08/08/2022 | |
TXG | 10x Genomics | -$0.11 | -$0.31 | -$0.38 | -22.58% | $105.82M | $113.34M | $114.50M | 1.02% | 05/04/2022 | |
TXG | 10x Genomics | -$0.08 | -$0.09 | -$0.16 | -77.78% | $112.22M | $148.53M | $143.53M | -3.37% | 02/16/2022 | |
TXG | 10x Genomics | -$0.65 | -$0.20 | -$0.15 | 25.00% | $71.82M | $122.62M | $125.30M | 2.18% | 11/03/2021 | |
TXG | 10x Genomics | -$0.41 | -$0.26 | -$0.10 | 61.54% | $42.91M | $112.85M | $115.84M | 2.65% | 08/04/2021 | |
TXG | 10x Genomics | -$0.22 | -$0.27 | -$0.11 | 59.26% | $71.91M | $102.51M | $105.82M | 3.23% | 05/05/2021 | |
TXG | 10x Genomics | -$0.07 | -$0.23 | -$0.08 | 65.22% | $75.29M | $100.40M | $112.22M | 11.77% | 02/17/2021 | |
TXG | 10x Genomics | -$0.33 | -$0.30 | -$0.65 | -116.67% | $61.21M | $61.23M | $71.82M | 17.29% | 11/10/2020 |
10x Genomics (TXG) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $0.28 | $-0.19 | 247.4 % |
| Q1 | 2025-05-08 | $-0.28 | $-0.29 | 3.45 % |
| Q4 | 2025-02-12 | $-0.40 | $-0.11 | -263.6 % |
| Q3 | 2024-10-29 | $-0.30 | $-0.34 | 11.8 % |
10x Genomics (TXG) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-08-07 | $172.90M | $139.48M | 24.0 % |
| Q1 | 2025-05-08 | $154.88M | $131.91M | 17.4 % |
| Q4 | 2025-02-12 | $165.02M | $164.98M | 0.02 % |
| Q3 | 2024-10-29 | $151.65M | $158.63M | -4.40 % |
PREGUNTAS FRECUENTES
¿Cuándo 10x Genomics (NASDAQ:TXG) publicará los resultados?
Está previsto que 10x Genomics (TXG) presente resultados el noviembre 6, 2025. Los últimos resultados se publicaron el agosto 7, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de 10x Genomics (NASDAQ:TXG)?
El BPA real fue de $0.28, que superó la estimación de $-0.19.
¿Cuáles fueron los ingresos de 10x Genomics (NASDAQ:TXG)?
Los ingresos reales fueron $172.9M, que superó la estimación de $139.5M.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.